HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael J. Jurmann Thorsten Drews Miralem Pasic Roland Hetzer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jurmann, M. J. Articles by Hetzer, R. Search for Related Content PubMed PubMed Citation Articles by Jurmann, M. J. Articles by Hetzer, R. Related Collections Congestive Heart Failure Coronary disease Mechanical Circulatory Assistance Transplantation - heart

Eur J Cardiothorac Surg 2004;25:610-618
© 2004 Elsevier Science NL

Permanent mechanical circulatory support in patients of advanced age

Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

Received 18 July 2003; received in revised form 3 January 2004; accepted 7 January 2004.

^* Corresponding author. Tel.: +49-30-459-32000; fax: +49-30-459-32100
e-mail: jurmann{at}dhzb.de

Objective: This study details our initial results of long-term left ventricular assist device (LVAD) support in patients suffering from catecholamine-dependent end-stage heart failure or cardiogenic shock with age above 65 years or age above 60 and contraindications to cardiac transplantation. Methods: Between September 2000 and July 2002, 27 patients received implantation of left ventricular assist devices (Micromed DeBakey (n=15), Berlin Heart Excor (n=6), Arrow Lion Heart (n=4) and Novacor N100 (n=2)). The mean age of this group was 66.2±4.1 (60–77) years. The patients presented with the following features by the time of LVAD implantation: failure of weaning from inotropic support (78%), either profound cardiogenic shock (37%) or instable hemodynamic status (22%), high-dose inotropic (52%) or intraaortic balloon pump support (11%), dialysis (15%), artificial ventilation (15%), and at least one previous cardiac procedure (44%). Results: The cumulative survival rate for the whole group was 63% at 30 days, 30% at 180 days, and 22% at 2 years. The presence of preoperative cardiogenic shock was associated with a higher perioperative mortality rate. Late complications (n=7) included replacement of two thrombosed DeBakey LVADs and five late deaths secondary to thrombembolism/intracranial hemorrhage (DeBakey LVAD, n=3) or septicemia (n=2). As of May 15, 2003, six patients remain on LVAD support for an average of 653 (339–953) days, three patients now for more than 2 years. Ten patients were discharged home to spend 73% of their life span on out-of-hospital long-term LVAD support. Conclusion: This study reports the first single-center experience of permanent LVAD support in patients of advanced age. For this initial experience, many patients with critical circulatory status and previous cardiac operations were included and a high postoperative mortality rate was encountered among them. Older age and associated multimorbidity are the key determinants rendering the conditions of LVAD therapy for this patient cohort to be different from the bridge-to-transplant experience. The LVADs employed in this study showed different capabilities with regard to long-term support. Our experience shows that permanent mechanical circulatory support does have the potential to evolve as a treatment option in selected elderly patients with end-stage heart failure.

Key Words: Heart failure • Cardiogenic shock • Cardiac transplantation • Left ventricular assist device • Ventricular assist device • Circulatory support

This article has been cited by other articles:

				M. J. Wilhelm, C. Schmid, and H. H. Scheld Reply to the Editor: J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 210 - 211. [Full Text] [PDF]

				N. C. Dang, V. K. Topkara, B. T. Kim, M. L. Mercando, J. Kay, and Y. Naka Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1302 - 1309. [Abstract] [Full Text] [PDF]

				A. El-Banayosy, L. Arusoglu, M. Morshuis, L. Kizner, G. Tenderich, P. Sarnowski, H. Milting, and R. Koerfer CardioWest Total Artificial Heart: Bad Oeynhausen Experience Ann. Thorac. Surg., August 1, 2005; 80(2): 548 - 552. [Abstract] [Full Text] [PDF]

				C. Schmid, C. Etz, H. Welp, M. Rothenburger, H. Reinecke, M. Schafers, Ch. Schmidt, and H.H. Scheld Clinical situations demanding weaning from long-term ventricular assist devices Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 730 - 735. [Abstract] [Full Text] [PDF]